Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Obiageri O. Obodozie-Ofoegbu"'
Autor:
Kana Tai Lucero, Obiageri O Obodozie-Ofoegbu, Zohra Nooruddin, Kellie Ryan, Alyssa Castillo, Amanda M Moore, Xavier Jones, Christopher R Frei
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 29:420-430
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f44a83e0568998e431273b2c570e4ac8
https://doi.org/10.18553/jmcp.2023.29.4.420
https://doi.org/10.18553/jmcp.2023.29.4.420
Autor:
Kellie Ryan, Daniel McHugh, Christopher R. Frei, Ricardo Uribe, Snegha Ananth, Samantha Galley, Courtney Baus, Zohra Nooruddin, Juan Tavera, Michelle Janania-Martinez, David Gregorio, Manuel Ricardo Espinoza-Gutarra, Michael M. Song, Kathleen Franklin, Chengwen Teng, Prathibha Surapaneni, Obiageri O Obodozie-Ofoegbu, Xavier Jones, Hannah Le
Publikováno v:
Leukemia & Lymphoma. 62:1664-1673
The US veteran population has a high proportion of chronic lymphocytic leukemia (CLL) risk factors. Using the Veterans Health Administration (VHA) population, we conducted a retrospective chart review of 1205 CLL patients who initiated treatment with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38e7d50290aa01bb234afc7ead5b2926
https://doi.org/10.1080/10428194.2021.1876863
https://doi.org/10.1080/10428194.2021.1876863
Autor:
Kana Tai Lucero, Christopher R. Frei, Kellie J. Ryan, Obiageri O. Obodozie-Ofoegbu, Amanda M. Moore, Chengwen Teng, Xavier Jones, Zohra Nooruddin
Publikováno v:
Blood. 140:9915-9916
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29e25b79b395df9e248e6daded9d58df
https://doi.org/10.1182/blood-2022-163797
https://doi.org/10.1182/blood-2022-163797
Publikováno v:
Am J Infect Control
Background Infectious Diseases Society of America guidelines recommend empiric antipseudomonal combination therapy when Pseudomonas is suspected. However, combination antipseudomonal therapy is controversial. This study compares all-cause 30-day mort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50a021d510a202e5c3504d8155b9f139
https://doi.org/10.1016/j.ajic.2019.02.018
https://doi.org/10.1016/j.ajic.2019.02.018
Autor:
Elizabeth A. Walter, Chengwen Teng, Christopher R. Frei, Obiageri O Obodozie-Ofoegbu, Daryl Kevin S. Gaspar
Publikováno v:
International Journal of Medical Sciences
Introduction: Macrolides, linezolid, imipenem-cilastatin, fluoroquinolones, penicillin combinations, and ceftriaxone are known to be associated with Torsades de pointes/QT prolongation (TdP/QTP). Other antibiotics may also lead to TdP/QTP, but no stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23224981b759e228c08cea6370d3bb43
https://doi.org/10.7150/ijms.34141
https://doi.org/10.7150/ijms.34141
Publikováno v:
International Journal of Medical Sciences
Introduction: Antibiotic use is an important risk factor for Clostridium difficile infection (CDI). Prior meta-analyses have identified antibiotics and antibiotic classes that pose the greatest risk for CDI; however, CDI epidemiology is constantly ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6d1d10a2046c24290b29d8ac88969bd
https://doi.org/10.7150/ijms.30739
https://doi.org/10.7150/ijms.30739
Autor:
Kellie Ryan, Obiageri O Obodozie-Ofoegbu, Zohra Nooruddin, Amanda M. Moore, Alyssa Castillo, Kana Tai Lucero, Christopher R. Frei, Xavier Jones
Publikováno v:
Blood. 138:340-340
Introduction Since the introduction of NAs in 2013, the treatment paradigm for CLL has changed significantly with the increased uptake of NAs for first line (1L) and refractory CLL. NA have introduced a personalized approach to CLL treatment that con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39dfd127e8c2a1ac8e44e4a32e8a9a6a
https://doi.org/10.1182/blood-2021-146860
https://doi.org/10.1182/blood-2021-146860
Autor:
Tiwalade A, Adelakun, Xiao, Ding, Rose M, Ombati, Ning-Dong, Zhao, Obiageri O, Obodozie-Ofoegbu, Ying-Tong, Di, Yu, Zhang, Xiao-Jiang, Hao
Publikováno v:
Natural product research. 34(21)
Twenty-two diterpenoids (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c0296768f426e7dd0155f2b60c6cdfc1
https://pubmed.ncbi.nlm.nih.gov/31084207
https://pubmed.ncbi.nlm.nih.gov/31084207
Autor:
Ying-Tong Di, Xiao-Jiang Hao, Ning-Dong Zhao, Obiageri O Obodozie-Ofoegbu, Rose Ombati, Xiao Ding, Yu Zhang, Tiwalade A. Adelakun
Twenty-two diterpenoids (1–22), including two new ones (1, a tigliane-type diterpenoid and 8, an abietane-type diterpenoid) were isolated from the roots of Euphorbia fischeriana Steud. Among them, compounds 4, 7, 12, 14–16, 19–21 are isolated f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::194344cbd6b45d39644f07dbfa411b9e
Autor:
Prathibha Surapaneni, Zohra Nooruddin, Hannah Le, Manuel Ricardo Espinoza-Gutarra, Daniel McHugh, Juan Tavera, Samantha Galley, Kellie Ryan, Michael Song, Chengwen Teng, Kathleen Franklin, David Gregorio, Snegha Ananth, Xavier Jones, Christopher R. Frei, Ricardo Uribe, Michelle Janania Martinez, Obiageri O Obodozie-Ofoegbu
Publikováno v:
Journal of Clinical Oncology. 38:252-252
252 Background: Previously, we reported that adverse events (AEs) were the top reason for dose reductions in VHA patients on novel agents. Some AEs might be problematic but might not directly lead to dose reduction; however, these concomitant AEs sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a4d20969d77c326e68719e7822763e5
https://doi.org/10.1200/jco.2020.38.29_suppl.252
https://doi.org/10.1200/jco.2020.38.29_suppl.252